Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)
Expert Opinion on Investigational Drugs - United Kingdom
doi 10.1080/13543784.2020.1703948
Full Text
Open PDFAbstract
Available in full text
Date
December 23, 2019
Authors
Publisher
Informa UK Limited